Skip to content

Clinical trials

Phase 1 Leukemia, Lymphocytic, Chronic, B-Cell trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 1 Country / region: Switzerland Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20121
20161
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ImmunoGen, Inc.1
MEI Pharma, Inc.1
Nurix Therapeutics, Inc.1
Prelude Therapeutics1
Swiss Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell5
Lymphoma, B-Cell, Marginal Zone4
Lymphoma, Large B-Cell, Diffuse4
Lymphoma, Mantle-Cell4
Lymphoma, Follicular3
Lymphoma2
Lymphoma, Non-Hodgkin2
Waldenstrom Macroglobulinemia2
Burkitt Lymphoma1
Hematologic Neoplasms1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.